ATF4 leads to glaucoma by promoting protein synthesis and ER client protein load
Glaucoma is the leading cause of irreversible blindness affecting over 70 million people worldwide. Here, the authors show that inhibition of chronic ER stress-induced ATF4-CHOP-GADD34 signaling pathway rescues pathology in mouse models of glaucoma, thus suggesting a possible treatment strategy.
Guardado en:
Autores principales: | Ramesh B. Kasetti, Pinkal D. Patel, Prabhavathi Maddineni, Shruti Patil, Charles Kiehlbauch, J. Cameron Millar, Charles C. Searby, VijayKrishna Raghunathan, Val C. Sheffield, Gulab S. Zode |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/066b0588eecd45bc90ad78f0bc0e7443 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Astragaloside IV Attenuates Ocular Hypertension in a Mouse Model of TGFβ2 Induced Primary Open Angle Glaucoma
por: Ramesh B. Kasetti, et al.
Publicado: (2021) -
Proteomics reveals signal peptide features determining the client specificity in human TRAP-dependent ER protein import
por: Duy Nguyen, et al.
Publicado: (2018) -
Zika Virus Infects Trabecular Meshwork and Causes Trabeculitis and Glaucomatous Pathology in Mouse Eyes
por: Pawan Kumar Singh, et al.
Publicado: (2019) -
Competing protein-protein interactions regulate binding of Hsp27 to its client protein tau
por: Rebecca Freilich, et al.
Publicado: (2018) -
Forkhead Box Protein P3 (FOXP3) Represses ATF3 Transcriptional Activity
por: Chiung-Min Wang, et al.
Publicado: (2021)